Podcasts about Positron

Plus: AI chip startup Positron valued at $5 billion in new funding round. And laser fusion tech could play a new role in modern warfare. Imani Moise hosts. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

TIME STAMP INFO:00:00:35 Intros00:07:00 BREAKING: Asha Sharma CONFIRMS Project Positron | Physical Media Coming To XBOX Helix?00:43:00 Geoff Keighley's Opening Night Live Was REALLY Good, We Break Down Our TOP Picks!01:18:00 Outros

Si te gusta lo que escuchas y quieres apoyar esta empresita, ven a ver el programa en directo de lunes a jueves a las 18:00h en Twitch.tv/chiclanafriends

Si te gusta lo que escuchas y quieres apoyar esta empresita, ven a ver el programa en directo de lunes a jueves a las 18:00h en Twitch.tv/chiclanafriends

In Xbox Kompakt werfen wir jeden Samstag einen Blick zurück auf die vergangene Woche und fassen für euch die News-Highlights rund um unsere Lieblingskonsole zusammen - eigentlich bei YouTube, doch jetzt bekommt ihr alle Infos auch hier auf die Ohren!Inhalte dieser Folge im Detail:00:00 Hey Leute00:37 Spieledisc, Positron - https://t.co/63ic3pLRB101:31 Entlassungen - https://t.co/Dh4q1TFBbT06:24 Podcast + Feedback - https://t.co/K6pPHviTj610:04 Avowed + Fallout - https://t.co/HwN5b6OE9V11:40 Xbox Exclusives - https://t.co/xqKNX8HcEf14:34 Xbox Game Pass - https://t.co/yLgq3DEPaq15:29 Free Play Days - https://t.co/grYG0DlpVK15:41 Mortal Shell 2 - https://t.co/vJ0Ud1opEb15:54 Brigandine Abyss - https://t.co/H8vL25xJMV16:12 Subnautica 2 - https://t.co/RUvjjBc1lX16:23 Achilles - https://t.co/11ApMWYySQ16:58 Xbox Highlights - https://t.co/P0o8Qdyz4F17:10 Assassin's Creed - https://t.co/t1kH716yeI19:40 Vorschau20:00 Ciao ciao!

In Xbox Kompakt werfen wir jeden Samstag einen Blick zurück auf die vergangene Woche und fassen für euch die News-Highlights rund um unsere Lieblingskonsole zusammen - eigentlich bei YouTube, doch jetzt bekommt ihr alle Infos auch hier auf die Ohren!Inhalte dieser Folge im Detail:00:00 Hey Leute00:27 Spieledisc, Positron - https://t.co/63ic3pLRB106:58 Video-Podcast - https://t.co/02c9Ameqco07:15 Vorschau Juli - https://t.co/5BdUTWzSAD07:32 Kinguin - https://t.co/96I8AM7yfj08:04 Free Play Days - https://t.co/p9ZYDUdGRO08:25 Remothered Remastered - https://t.co/k33LyIWLKM09:02 Guns of Eschaton - https://t.co/RmibAIosUI09:12 Cinder City - https://t.co/yvQpANtpNe09:38 Onimusha - https://t.co/plprfwXfkP09:50 Attack on Titan 3 - https://t.co/oZvbCyawNA10:07 Nickelodeon Tennis - https://t.co/zzNoXlCWYG10:20 Avatar Legends - https://t.co/LwsBq1duaR10:50 Outbound - https://t.co/MGkKF3D3Ad11:03 Albion Online - https://t.co/zOhAl6z36p11:12 World of Tanks - https://t.co/OcaPTEVfdT11:26 The Alters - https://t.co/ZNiF2c0j0M11:46 Xbox-Highlights - https://t.co/H8rzTcJizm11:59 RV There Yet - https://t.co/SNXkIhSWjO13:28 Vorschau13:53 Ciao ciao!

Doug Erwin sits down with Tristan Pollock, Managing Director of Generator's Electrify Nevada program, to talk about Reno's growing startup ecosystem, Nevada's strategic advantage in energy and hard tech, and why the region is positioned for a new wave of founder growth. They cover Tristan's path from startup founder to accelerator operator and investor, the role of AI in entrepreneurship, and how Nevada can turn speed, infrastructure, lifestyle, and deep-tech talent into a durable startup flywheel. Show notes In this episode of Growth Pioneers, Doug talks with Tristan Pollock about the next phase of Reno's startup ecosystem. Tristan shares how his journey from Minnesota to Silicon Valley, 500 Startups, climate investing, and global accelerator work eventually brought him to Reno. Now leading Generator's Electrify Nevada program, he is focused on helping energy, battery, manufacturing, industrial AI, and hard-tech founders break into Nevada's ecosystem faster. The conversation explores why Nevada has become such a compelling place for founders: proximity to Silicon Valley, fast permitting, major industrial infrastructure, lithium and geothermal strengths, renewable energy, the Tahoe/Reno lifestyle, and a growing base of startup success stories like Positron, Redwood Materials, Ampersand, and SendCutSend. Doug and Tristan also dig into AI's impact on founders, fundraising, outreach, and company building. Rather than treating AI as just better prompting, they talk about it as a new operating layer for entrepreneurs: helping people research, build, automate, and scale faster than ever before. The episode closes with a broader conversation about optimism, social impact, the future of work, and why curiosity may be the most important entrepreneurial skill in a period of rapid technological change. Key themes • Reno's ecosystem is moving from potential to sophistication. • Electrify Nevada helps founders speedrun market entry into Nevada. • Nevada's edge is strongest in energy, batteries, mining, manufacturing, logistics, hard tech, and industrial AI. • AI is changing how founders build, raise capital, find customers, and operate. • The next regional win is building a self-reinforcing startup flywheel: talent, capital, exits, reinvestment, and local founder density. • Optimism and curiosity matter in a moment where technology is changing faster than institutions can adapt.

Neste episódio, Paulo, Thiago, Rafael e Arthur falando de Futebol, Dark Horse, Thiago compra um Switch 2, rumores Xbox "Positron" (troca de discos por cópia digital), tapetes profissionais de DDR, Dance Dance Revolution, dancefitgaming.com.br, jogos de ritmo, Jubeat, Mixtape, Caio dos mil CDs, música como hobby, lançamento de Forza Horizon 6, vazamento de Forza, Michael (Jackson, o filme), Prince, Michael Jackson no Rio, Thriller, Bad, Paulinho da Costa, calçada da fama, Wiplash, In A Violent Nature, Weapons (A Hora do Mal), Zack Cregger, The Whitest Kids U'Know, Smile 2, XBOX Player VoiceTodos os links do godmode agora estão organizados aqui - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/godmode.podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Se for mandar email reclamando - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠contato@godmodepodcast.com⁠⁠⁠

Αλλάζουν πρόσωπα στο Xbox, η Capcom είναι ασταμάτητη, η SEGA παρατά το Super Game, ενώ η Roblox επιμένει στον πλανήτη χάπι. Get in touch: Email | Twitter Ι Facebook Group Hosted by: Elias Pappas - Facebook | Twitter | Instagram Manos Vezos - The Vez | Facebook | Twitter | Instagram Ι Apple Music M&A Atari acquires rights to first five Wizardry RPGs Pearl Abyss sells CCP back to its CEO for less than half what it paid, plus $20 million in crypto CCP Games rebrands as Fenris Creations following sale from Pearl Abyss "I'm not going to fight the Chinese Communist Party" – Why Eve Online firm CCP Games rebranded to Fenris Creations Immense Engine Guerrilla Games co-founder Arjan Brussee announces plans to build European-based games engine VS Studio SNK announces new studio lead by Tekken veteran Katsuhiro Harada Αποτελέσματα Remedy Remedy reports "stable" Q1 performance despite decreases in revenue and operating profit EA EA closes FY26 with "record" performance thanks to Battlefield 6 and Apex Legends Pearl Abyss Crimson Desert increases Pearl Abyss Q1 earnings more than fivefold to $220.6m SEGA Sega reports $31.6m net loss during FY26, cancels 'Super Game' project amid strategic pivot Capcom Capcom secures ninth consecutive year of profit boosted by Resident Evil Requiem Sony PlayStation records $765m impairment loss from Bungie as operating income falls 41.6% in Q4 Sony maps out how first-party PlayStation studios are utilising AI tools during development Nintendo Nintendo FY sales soar 98.6% to $14.6bn following launch of Switch 2 Nintendo hikes Switch 2 prices, revises console costs in Japan, US, Canada, and Europe Nintendo Announces $500 Switch 2 Bundle With Choice of First-Party Game Nintendo share value falls as president admits increased prices will "raise the barrier to purchase" Roblox Scaler Roblox announces AI-driven upscaler, which it claims will convert Roblox titles to photorealistic graphics Xbox Xbox Game Pass and Discord: Building on Our Partnership to Bring More Benefits to Players Nitro Now Comes with Xbox Game Pass and New Benefits. Welcome to Nitro Rewards. Discord Nitro subscribers to receive "starter edition" of Xbox Game Pass through new partnership "Project Saluki": A new Xbox Game Pass tier has been unearthed, alongside a curious "Positron" potential disc-to-digital program — and it could be huge Xbox announces leadership changes as it stops development of Gaming Copilot for console

Discord: https://discord.com/invite/mzZnJuVwdT |  SUSCRÍBETE  A NUESTRO CANAL DE YOUTUBE: |  https://www.youtube.com/@sonido_boom?sub_confirmation=1 |  NUESTRO CANAL PRINCIPAL: |  https://www.youtube.com/abuguet |   Esta semana Ep. 379:  (0:00) - Intro. ===EL CORAZÓN DE LAS CARTAS=== (1:27) - Jhonyboy_007: Queremos historias nuevas. (2:05) - @BieloPrusia: Yo nunca he jugado Star Fox. (9:34) - Jesus.m.hinojosa:  Star Fox es para los papás. ===TEMAS DE LA SEMANA=== (11:00) - El Nintendo Switch 2 sube de precio. (31:11) - Xbox anuncia Game Pass en colaboración con Discord. (40:15) - Saluki y Positron, los dos proyectos secretos de Xbox. (53:58) - Europa quiere hacerle la competencia a Unreal Engine.  (1:19:03) - Precios regionales aparecen en Playstation Store México. ===SPEEDRUN DE NOTICIAS=== (1:45:40) - Reino Unido pide cuentas a Rockstar. (1:46:49) - Double Fine ha decidido sindicalizarse.  (1:47:45) - MercurySteam (Metroid Dread) ha reportado despidos.  (1:47:53) - Capcom la está rompiendo, por noveno año en fila.  (1:50:05) - Konami también la está rompiendo, por 3er año consecutivo.  (1:50:21) - Creador de Tekken tiene nuevo estudio. (1:50:51) - eBay ha rechazado la “oferta” de compra de Gamestop.  (1:51:16) - Crimson Desert aumenta 2,584% en utilidades. (1:53:29) - Sega ha cancelado su “super juego”.  (1:54:07) - La secuela de Stellar Blade será multiplataforma. (1:55:05) - El steam controller grita si se te cae. (1:57:17) - Las ofertas y descuentos de la semana con el Arbano Peps.

We know why you're here every week. To answer that one burning question...  Where does Microsoft Solitaire Collection sit on the chats?   Now on with The Regular Show  

Forza Horizon 6, Subnautica, Outbound, Nintendo-prijsverhogingen, Sony, Marathon, Assassin's Creed Black Flag, Xbox Project Saluki en Positron, Starfield.

No Bom Dia, Minha Vida de hoje, Isadora Basile comenta o vazamento do e-mail da Best Buy que indica abertura de pré-venda de GTA 6 para 18 de maio — e a especulação de que um terceiro trailer pode vir junto; os codinomes internos do Xbox "Project Saluki" e "Positron", que apontam para um Game Pass específico para a China e um possível sistema de conversão de disco físico em digital; a confirmação velada da Amazon de que o MMO de Senhor dos Anéis foi cancelado; os resultados recordes da Capcom no ano fiscal de 2026, com 59 milhões de jogos vendidos e Resident Evil Requiem como grande motor; a nova data do filme live-action de Zelda, antecipado para 30 de abril de 2027; e a lineup do PS Plus Extra de maio, com Red Dead Redemption 2 e Star Wars Outlaws disponíveis a partir do dia 19._________________❤️____________________

Sponsorem dzisiejszego odcinka jest aplikacja BookBeat, która służy do słuchania audiobooków i czytania e-booków.KOD: ROCKIBORYShttps://www.bookbeat.com/pl/rockiborys?utm_source=spotify&utm_medium=podcast&utm_campaign=PL-rock-i-borys-action-3125&utm_content=textlink-spot-epi-description-30db&utm_term=deal3(00:00) Bookbeat - fragment sponsora(13:20) Co tam u nas słychać(14:55) Steam Controller(25:12) Diablo 4 Lord of Hatred(31:35) Saros(38:44) Directive 8020(51:47) Struktura Kryształu - 35mm online(56:30) Spider-Noir(01:02:44) Xbox wchodzi do ChinJak wygląda chiński rynek gier?https://youtu.be/kzlLR6icmB0?si=GpKP1rAKTTJqtDTL"Project Saluki": A new Xbox Game Pass tier has been unearthed, alongside a curious "Positron" potential disc-to-digital program — and it could be hugehttps://www.windowscentral.com/gaming/xbox/project-saluki-a-new-xbox-game-pass-tier-has-been-unearthed-alongside-a-curious-positron-disc-to-digital-program-and-it-could-be-hugeDiablo IV: Lord of Hatred | Launch Trailerhttps://youtu.be/Qu1PmW-Qzxk?si=RdUje3Uhjw78dC4ASaros - Launch Trailer | PS5 Gameshttps://youtu.be/rj_1CzKUR4w?si=7DfCjVLgK9qc4Vg6Directive 8020 | Launch Trailerhttps://youtu.be/a75f2z_I7QU?si=NJjfp0yy6fuyT7_MGrupa Rock i Borys na FB - https://www.facebook.com/groups/805231679816756/Podcast Remigiusz "Pojęcia Nie Mam" Maciaszekhttps://tinyurl.com/yfx4s5zzShorty Rock i Boryshttps://www.facebook.com/rockiboryshttps://www.tiktok.com/@borysniespielakSerwer Discord podcastu Rock i Borys!https://discord.com/invite/AMUHt4JEvdSłuchaj nas na Lectonie: https://lectonapp.com/p/rckbrsSłuchaj nas na Spotify: https://spoti.fi/2WxzUqjSłuchaj nas na iTunes: https://apple.co/2Jz7MPSProgram LIVE w niedzielę od osiemnastej - https://jarock.pl/live/rockRock i Borys to program o grach, technologii i życiu

Mitesh Agrawal has a background in Mechanical Engineering. He was one of the co-founders of Lambda, a company in the supercomputing space, where he spent 8.5 years working on everything under the sun. He's very grateful to be in an industry that is booming, but also aligns with his personal interests. Outside of tech, he is married to an ultra supportive wife, and is enjoying being a new father. He enjoys playing tennis, when he can find time to get to the court, and enjoys a good sci-fi book. He mentioned the Foundation series was one of his favorites, but admits it changes depending on the season.In 2023, the officers at Mitesh's current venture noticed all of the advancements of AI - in particular, model sizes getting larger. What they realized was that when it comes to inference, memory capacity quickly became a problem... and with this, he and the team got excited about building a new architecture to make it better.This is the creation story of Positron.SponsorsUnblockedTECH DomainsMezmoBraingrid.aiLinkshttps://www.positron.ai/https://www.linkedin.com/in/mitesh7/Support this podcast at — https://redcircle.com/codestory/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Positron AI is a 2+ year old silicon company targeting decode-heavy AI inference workloads where memory bandwidth, not compute, is the bottleneck. Launching end of 2025/early 2026, their architecture delivers 2TB of on-chip memory capacity versus Nvidia Rubin's 0.4TB—enabling 3-5x better performance per dollar and per watt for reasoning models, code generation, and video generation. In this episode, Mitesh Agrawal shares how Positron identified the memory bandwidth gap in a market where Nvidia controls 90%+ share, why they're prioritizing anchor customer commitments over product completion, and the hard lessons from Lambda Labs about rapid iteration and customer-driven optionality. Topics Discussed: Positron's technical approach: focusing on memory bandwidth and capacity over compute for inference workloads Why decode-heavy applications (reasoning models, video generation, code generation) are becoming memory-bound The challenge of selling silicon to hyperscalers when Nvidia controls 90%+ of the market Building optionality into product strategy: air cooling vs. liquid cooling as unexpected GTM advantage Learning to sell hardware before the product ships and why anchor customers matter Lambda Labs experience: lessons on rapid iteration and thoughtful hiring during hypergrowth Maintaining engineering-centricity: 47 of 50 employees focused on product development GTM Lessons For B2B Founders: Find technical bottlenecks in high-growth markets: Positron identified that memory bandwidth wasn't scaling as fast as compute, creating a bottleneck for inference workloads. While Nvidia dominates with 90%+ market share, they optimize for training revenue. B2B founders should analyze where dominant players are constrained by their own economics or existing roadmaps, then build specifically for those underserved segments. Markets default to oligopoly, not monopoly: Mitesh observed that customers actively seek alternatives even when one vendor is superior. "Markets want oligopoly structure to exist," he explained. B2B founders shouldn't be discouraged by dominant incumbents—customers want optionality for leverage, supply chain resilience, and risk management. Position yourself as the credible alternative in specific use cases. Discover optionality through customer conversations: Positron initially pitched performance per watt without realizing air cooling capability was a major advantage. Only after selling their first product did they learn customers valued deploying in existing data centers without infrastructure overhauls. B2B founders should systematically debrief early customers to uncover which features solve problems you didn't anticipate. Sell before shipping in hardware: The biggest priority between now and product launch is securing anchor customers willing to commit purchase orders. "If you have someone to build for, the fillip it gives the engineering team, the confidence it gives operations and supply chain vendors—we underwrite that," Mitesh emphasized. Pre-sales derisk production, prove demand, and create momentum. B2B hardware founders should treat early customer commitments as product validation, not just revenue. Build storytelling into technical sales: Convincing customers to buy unshipped hardware requires months of narrative work. "It becomes like, if I sell it to you, why will it be useful to you? Is it going to save cost? Attract new customers? Drive growth?" Success means co-creating the internal business case your champion will present. B2B founders should invest heavily in helping customers articulate ROI and strategic value before asking for commitments. Maintain rapid iteration cadence: Nvidia ships every 12-15 months versus the industry standard of 3-4 years. "If you tell me that in 10 years you've launched 10-12 products in silicon, I will give much more probability we will be successful," Mitesh stated. B2B founders should structure operations and product development for continuous iteration rather than big-bang releases, even in traditionally slow-moving industries. Delay non-engineering hires until product proves itself: With 47 of 50 people in engineering, Positron has consciously prioritized product over go-to-market. "It was a very conscious decision," Mitesh emphasized. For deep-tech companies, this focus ensures you can actually deliver before scaling sales. B2B founders should resist pressure to build balanced teams early—let roles emerge from real needs rather than theoretical org charts.     Sponsors: Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe. www.GlobalTalent.co Don't Miss: New Podcast Series — How I Hire Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role. Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM

The investment comes from backers including the Qatar Investment Authority as demand for chips beyond Nvidia soars and as Qatar aims to build out its AI infrastructure. Also, To build and sell more of its autonomous underwater vehicles (AUVs), Apeiron Labs recently closed a $9.5 million Series A round led by Dyne Ventures, RA Capital Management Planetary Health and S2G Investments, the company exclusively told TechCrunch. Assembly Ventures, Bay Bridge Ventures, and TFX Capital participated. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Producing the highest performance, lowest power, and best total cost of ownership solution for AI transformer model inference.

Today's show:In this founder-focused episode of This Week in Startups, we sit down with Republic's Kendrick Nguyen to learn more about the company's efforts to make the private markets accessible to the common investor. Best known for its work in equity crowdfunding, the Valor-backed startup now offers access to secondary shares, tokenized assets, and much more. Following, TWiST spoke with Positron CEO Mitesh Agrawal to learn more about his company's inference-focused AI compute hardware. Related to fellow TWiST500 company Etched, Positron is building custom chips to take on the computing work required to deliver your AI query results faster and with less power draw than what GPUs can offer. With AI inference compute demand rising, the fellow Valor-backed startup has even more powerful systems coming to market in 2026 that have our hopes up that the AI cost curve can continue to point downward.Timestamps:0:00 - A future with more efficient and accessible intelligence0:41, the following sponsors are mentioned: AlphaSense, Vanta, and Oracle Cloud Infrastructure1:26 - Introduction to the episode and the two featured companies, Republic and Positron2:43 - The history and purpose of Republic, a financial crowdfunding platform5:39 - Discussion of the current state and growth of equity crowdfunding9:19 - Kendrick Nguyen explains Republic's role as a financial infrastructure company, not a competitor to venture capital firms11:17 - Sponsor: Oracle Cloud Infrastructure12:25 - Republic's different products, Republic Capital and Republic Venture, are explained14:00 - The challenges and progress of secondary trading for non-accredited investors20:14 - Sponsor: Vanta21:21 - The concept of a unified "e-finance" infrastructure is introduced25:45 - Positron CEO Mitesh Agarwal discusses the future of AI chips and the limitations of current GPUs for inference workloads31:12 - Sponsor: AlphaSense32:22 - Discussion on the inefficiency of GPUs for inference and how Positron's Atlas system addresses it38:30 - Positron's strategy of using their Atlas system to prove their technology and generate revenue42:51 - The market shift from AI training to inference and the future of Positron's chips51:14 - The confidence in Positron's capital efficiency and their ability to compete with NVIDIA52:47 - Positron's focus on linear algebra acceleration rather than just transformersSubscribe to the TWiST500 newsletter: https://ticker.thisweekinstartups.comCheck out the TWIST500: https://www.twist500.comSubscribe to This Week in Startups on Apple: https://rb.gy/v19fcpFollow Lon:X: https://x.com/lonsFollow Alex:X: https://x.com/alexLinkedIn: ⁠https://www.linkedin.com/in/alexwilhelmFollow Jason:X: https://twitter.com/JasonLinkedIn: https://www.linkedin.com/in/jasoncalacanisThank you to our partners:(09:04) Netsuite - Download the ebook CFO's Guide to AI and Machine Learning for free at https://www.netsuite.com/twist(21:20) Coda - Empower your startup with Coda's Team plan for free—get 6 months at https://www.Coda.io/twist(31:43) .TECH: Say it without saying it. Head to get.tech/twist or your favorite registrar to get a clean, sharp .tech domain today.Great TWIST interviews: Will Guidara, Eoghan McCabe, Steve Huffman, Brian Chesky, Bob Moesta, Aaron Levie, Sophia Amoruso, Reid Hoffman, Frank Slootman, Billy McFarlandCheck out Jason's suite of newsletters: https://substack.com/@calacanisFollow TWiST:Twitter: https://twitter.com/TWiStartupsYouTube: https://www.youtube.com/thisweekinInstagram: https://www.instagram.com/thisweekinstartupsTikTok: https://www.tiktok.com/@thisweekinstartupsSubstack: https://twistartups.substack.comSubscribe to the Founder University Podcast: https://www.youtube.com/@founderuniversity1916

  WFNMB and the AOCNMB meetingsIn this podcast, we talk about the upcoming meetings of the World Federation of Nuclear Medicine and Biology and the Asia Oceania Congress of Nuclear Medicine and Biology  https://www.wfnmb.org/https://aocnmb2025.com/TAGS WFNMB,AOCNMB,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  WFNMB and the AOCNMB meetingsIn this podcast, we talk about the upcoming meetings of the World Federation of Nuclear Medicine and Biology and the Asia Oceania Congress of Nuclear Medicine and Biology  https://www.wfnmb.org/https://aocnmb2025.com/TAGS WFNMB,AOCNMB,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  WFNMB and the AOCNMB meetingsIn this podcast, we talk about the upcoming meetings of the World Federation of Nuclear Medicine and Biology and the Asia Oceania Congress of Nuclear Medicine and Biology  https://www.wfnmb.org/https://aocnmb2025.com/TAGS WFNMB,AOCNMB,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  WFNMB and the AOCNMB meetingsIn this podcast, we talk about the upcoming meetings of the World Federation of Nuclear Medicine and Biology and the Asia Oceania Congress of Nuclear Medicine and Biology  https://www.wfnmb.org/https://aocnmb2025.com/TAGS WFNMB,AOCNMB,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Nuclear Medicine Physics ToolsAndrew Chacon @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}In this podcast, we chat to Andrew Chacon at the ANZSNM, who has made a great set of tools for everyone to download and use for physicists, technologists, doctors, and everyone in nuclear medicine. Links below.  https://github.com/achacon01/nuclearMedicineToolsWebsitehttps://achacon01.github.io/nuclearMedicineToolsWebsite/index.htmlTAGS ANZSNM25,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST,AI,Austin @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Nuclear Medicine Physics ToolsAndrew Chacon @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}In this podcast, we chat to Andrew Chacon at the ANZSNM, who has made a great set of tools for everyone to download and use for physicists, technologists, doctors, and everyone in nuclear medicine. Links below.  https://github.com/achacon01/nuclearMedicineToolsWebsitehttps://achacon01.github.io/nuclearMedicineToolsWebsite/index.htmlTAGS ANZSNM25,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST,AI,Austin @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Nuclear Medicine Physics ToolsAndrew Chacon @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}In this podcast, we chat to Andrew Chacon at the ANZSNM, who has made a great set of tools for everyone to download and use for physicists, technologists, doctors, and everyone in nuclear medicine. Links below.  https://github.com/achacon01/nuclearMedicineToolsWebsitehttps://achacon01.github.io/nuclearMedicineToolsWebsite/index.htmlTAGS ANZSNM25,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST,AI,Austin @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

  Nuclear Medicine Physics ToolsAndrew Chacon @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}In this podcast, we chat to Andrew Chacon at the ANZSNM, who has made a great set of tools for everyone to download and use for physicists, technologists, doctors, and everyone in nuclear medicine. Links below.  https://github.com/achacon01/nuclearMedicineToolsWebsitehttps://achacon01.github.io/nuclearMedicineToolsWebsite/index.htmlTAGS ANZSNM25,PET,Podcast,Nuclear,Imaging,Therapy,NuclearMedicine,NIF,Physics,UNIMELB,MBCIU,Positron,NUCCAST,AI,Austin @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-469750017 -1040178053 9 0 511 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} Please let me know what you think about the video versions of the podcast.I am also looking for new material so please get in touch with me if you can contributewith an interview.Direct link to iTuneshttps://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2Older podcastshttps://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/.The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/Please pass on information about this podcast to your colleagues and to your CPD provider.Link to Video Link to Video fileLink to Audio file Link to Audio fileOr you can subscribe by entering your email address below and you will be informed of new episodesEnter your email address:Delivered by FeedBurnerMost importantly of all please help this podcast by contributing your opinions, Sound files, and emailsnucmedpodcast@gmail.comAll contributions welcome, especially as sound files to nucmedpodcast@gmail.com.@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}

In this episode of R Weekly Highlights: We have a six-month follow-up perspective from an early Positron user, how the current landscape of AI tools perform when learning the ropes with the Tidyverse, and how you can create your first Observable plot while using R for data munging.Episode LinksThis week's curator: Jon Carroll - @jonocarroll@fosstodon.org (Mastodon) & @jonocarroll.fosstodon.org.ap.brid.gy (Bluesky) & @carroll_jono (X/Twitter)Positron: current joys and painsLearning the tidyverse with the help of AI toolsObservable for R usersEntire issue available at rweekly.org/2025-W15Supplement ResourcesPositron +1e https://open-vsx.org/extension/grrrck/positron-plus-1-eVanishing Gradients episode 47 (The Great Pacific Garbage Patch of Code Slop with Joe Reis) https://vanishinggradients.fireside.fm/47Observable color palette viewer https://observablehq.com/plot/features/scales#color-scalesObservable Plots (R/Pharma 2024 Workshop Series) https://www.youtube.com/watch?v=M6fP68XnacMSupporting the showUse the contact page at https://serve.podhome.fm/custompage/r-weekly-highlights/contact to send us your feedbackR-Weekly Highlights on the Podcastindex.org - You can send a boost into the show directly in the Podcast Index. First, top-up with Alby, and then head over to the R-Weekly Highlights podcast entry on the index.A new way to think about value: https://value4value.infoGet in touch with us on social mediaEric Nantz: @rpodcast@podcastindex.social (Mastodon), @rpodcast.bsky.social (BlueSky) and @theRcast (X/Twitter)Mike Thomas: @mike_thomas@fosstodon.org (Mastodon), @mike-thomas.bsky.social (BlueSky), and @mike_ketchbrook (X/Twitter) Music credits powered by OCRemixSunny Side Up - Yoshi's Island DS - ZackParrish - https://ocremix.org/remix/OCR04558Costa Del Sol DANCE - Final Fantasy VII - Posu Yan - https://ocremix.org/remix/OCR00095

Thriving in a multi-lingual data science lifestyle while authoring your next Quarto project, putting LLMs to the scientific test with parsing manuscripts, and replicating a life-saving spatial visualization originally created over 170 years ago!Episode LinksThis week's curator: Ryo Nakagawara - @R_by_Ryo@mstdn.social (Mastodon) & @rbyryo.bsky.social (Bluesky) & @R_by_Ryo) (X/Twitter)Creating multilingual documentation with QuartoThe ellmer package for using LLMs with R is a game changer for scientists{SnowData} 1.0.0: Historical Data from John Snow's 1854 Cholera Outbreak MapEntire issue available at rweekly.org/2025-W12Supplement ResourcesWes McKinney & Hadley Wickham (on cross-language collaboration, Positron, career beginnings, & more) https://youtu.be/D-xmvFY_i7UTabby Quarto extension https://quarto.thecoatlessprofessor.com/tabby/Plotting the Past: The 1854 Cholera Outbreak Visualized in R https://simplifyingstats.wordpress.com/2025/01/18/plotting-the-past-the-1854-cholera-outbreak-visualised-in-r/Supporting the showUse the contact page at https://serve.podhome.fm/custompage/r-weekly-highlights/contact to send us your feedbackR-Weekly Highlights on the Podcastindex.org - You can send a boost into the show directly in the Podcast Index. First, top-up with Alby, and then head over to the R-Weekly Highlights podcast entry on the index.A new way to think about value: https://value4value.infoGet in touch with us on social mediaEric Nantz: @rpodcast@podcastindex.social (Mastodon), @rpodcast.bsky.social (BlueSky) and @theRcast (X/Twitter)Mike Thomas: @mike_thomas@fosstodon.org (Mastodon), @mike-thomas.bsky.social (BlueSky), and @mike_ketchbrook (X/Twitter) Music credits powered by OCRemixLost in a Nightmare - Castlevania: Symphony of the Night - Palpable - https://ocremix.org/remix/OCR03001Cammy's London Drizzle - Super Street Fighter II: The New Challengers - MkVaff - https://ocremix.org/remix/OCR00453

House Keeping Google / YouTube Update Join the Discord! Feedback Rust in the Linux Kernel. R Stuff What is R Again? Great presentation by John Chambers at UseR! 2006 https://www.r-project.org/conferences/useR-2006/Slides/Chambers.pdf The times have changed, now R is very much suited for production use and not just an academic research language Highly recommend reading Advanced R for more comprehensive details on the quirks of the language https://adv-r.hadley.nz/index.html R VS Python for Data? Different philosophies on the use of the language CRAN vs PyPi Interoperability becoming more mainstream now Visualization: R has always been leaps and bounds ahead (Grammar of Graphics, interactive widgets, etc) R Dev Stack? IDEs: RStudio, now Positron https://positron.posit.co/ Managing package installations with renv https://rstudio.github.io/renv/ Building web apps with Shiny: https://shiny.posit.co/ (I got so engrossed in this space that I created the Shiny Developer Series because of it) Early adopter of using Docker with R in devcontainers with VS-Code. New tech I'm excited about to enhance dev stacks and sharing apps WebAssembly with webR https://docs.r-wasm.org/webr/latest/ Shiny apps in webR? Yes you can https://github.com/RConsortium/submissions-pilot4-webR Managing dev environment combined with Nix: The rix package https://github.com/ropensci/rix (More organized links for show notes) R Language: https://r-project.org Posit (formerly RStudio): https://posit.co RStudio IDE https://posit.co/products/open-source/rstudio/ Positron (still in beta): https://positron.posit.co/ History of S and R presentation by John Chambers at useR! 2006: http://www.r-project.org/user-2006/Slides/Chambers.pdf Advanced R (2nd edition) by Hadley Wickham https://adv-r.hadley.nz/index.html Shiny - Easy interactive web applications with R: https://shiny.posit.co/ renv - Project environments for R: https://rstudio.github.io/renv/ R Markdown: https://rmarkdown.rstudio.com/ WebR - R in the browser: https://docs.r-wasm.org/webr/latest/ Rix - Reproducible Data Science environments for R with Nix: https://github.com/ropensci/rix Chromatic by ModRetro Chromatic: https://modretro.com/products/chromatic-tetris-bundle?variant=47637522579758 FPGA Mike's Review Eric's Thoughts Eric's Socials R Weekly Highlights: https://serve.podhome.fm/r-weekly-highlights Shiny Developer Series: https://shinydevseries.com/ R Podcast: https://r-podcast.org Bluesky: @rpodcast@bsky.social Mastodon: @rpodcast@podcastindex.social LinkedIn: https://www.linkedin.com/in/eric-nantz-6621617/ Coder's Socials Mike on X (https://x.com/dominucco) Mike on BlueSky (https://bsky.app/profile/dominucco.bsky.social) Coder on X (https://x.com/coderradioshow) Coder on BlueSky (https://bsky.app/profile/coderradio.bsky.social) Show Discord (https://discord.gg/k8e7gKUpEp) Alice (https://alice.dev)

In this episode, we are joined by Jake England of Millennium Machines. Brought to you by PCBWay (https://jle.vi/pcbway) and OctoEverywhere (https://octoeverywhere.com/welcome?id=podcast).Jake England is the mind behind Millennium Machines - an open-source CNC project pushing the boundaries of digital fabrication. Inspired by the success of projects like Voron and Positron, Millennium Machines is dedicated to making CNC technology more accessible, customizable, and community-driven.In this episode, we explore how Millennium Machines is redefining open-source CNC development, the challenges and rewards of running an open-source hardware project, upcoming machine releases, and why supporting open-source creators is crucial for the future of CNC and maker communities.

On this episode Doug speaks with Mitesh Agrawal the CEO of Positron.ai. Positron is advancing the world of AI hardware right here in the Biggest Little City, with their first product that provides 3X the performance of NVIDA at a lower cost. They discuss the changing landscape of AI, the importance of purpose built hardware and Positrons unique value. They discuss the Positron team, their investors and their success to date as well as dive in the future for them in our region.

The future of R-Universe looks even brighter for 2025 and beyond, revisiting the key factors for possibly switching to the Positron IDE, and why there is more than meets the eyes when it comes to the potential of LLMs and AI (even in highly-regulated industries).Episode LinksThis week's curator: Eric Nantz - @rpodcast@podcastindex.social (Mastodon), @rpodcast.bsky.social (BlueSky), and @theRcast (X/Twitter)R-Universe Named R Consortium's Newest Top Level ProjectPositron vs RStudio - is it time to switch?Summer is Coming: AI for Shiny, R, and PharmaEntire issue available at rweekly.org/2024-W50Supplement ResourcesrOpenSci Blog Post https://ropensci.org/blog/2024/12/03/r-universe-r-consortium-tlp/Positron IDE - A new IDE for data science https://drmowinckels.io/blog/2024/positron/Fun with Positron https://www.andrewheiss.com/blog/2024/07/08/fun-with-positron/Open VSX Registry https://open-vsx.orgPower Mode Extension https://open-vsx.org/extension/hoovercj/vscode-power-modeJoe Cheng's slides from R/Pharma keybote https://jcheng5.github.io/pharma-ai-2024/#/title-slideR Consortium Submissions Pilot 2 Shiny Application https://github.com/RConsortium/submissions-pilot2Daniel Sebanes Bove & Joe Cheng - Discussion of R/Pharma Keynote https://youtu.be/AU1MmcXYnJ0?si=A3V9JHYdZLiz-lvvPractical Tips for Using Generative AI in Data Science Workflows https://youtu.be/rPeOdc8jTSE?si=APtIhpRqlh2I_Ek1Apple Music Wrapped in R https://www.andrewheiss.com/blog/2024/12/04/apple-music-wrapped-r/Predicting Best Picture at the 2025 Academy Awards https://www.markhw.com/blog/oscars2025Navidrome - Your Personal Streaming Service https://www.navidrome.org/Scrubbing your music with Maloja https://wenkdth.org/posts/maloja-scrobbling/Supporting the showUse the contact page at https://serve.podhome.fm/custompage/r-weekly-highlights/contact to send us your feedbackR-Weekly Highlights on the Podcastindex.org - You can send a boost into the show directly in the Podcast Index. First, top-up with Alby, and then head over to the R-Weekly Highlights podcast entry on the index.A new way to think about value: https://value4value.infoGet in touch with us on social mediaEric Nantz: @rpodcast@podcastindex.social (Mastodon), @rpodcast.bsky.social (BlueSky) and @theRcast (X/Twitter)Mike Thomas: @mike_thomas@fosstodon.org (Mastodon), @mike-thomas.bsky.social (BlueSky), and @mike_ketchbrook (X/Twitter) Music credits powered by OCRemixThe Traveling Band's Last Song - Wild Arms: Armed and Dangerous - Artem Bank - https://ocremix.org/remix/OCR02588Secrets Abound - Final Fantasy - Midgarian Sky - https://ocremix.org/remix/OCR02452

Is it possible for a startup to compete with NVIDIA, the $1 trillion behemoth dominating AI hardware? Thomas Sohmers and his team at Positron are betting they can and they're moving at lightning speed to prove it. In this episode, Chris Saad sits down with Thomas Sohmers, founder and CEO of Positron, to explore how this ambitious startup is aiming to disrupt the AI chip market currently dominated by NVIDIA. In this episode, you will: Discover how Positron achieved working hardware in just 18 months, defying typical timelines for chip startups Learn about Positron's strategy for compatibility with existing AI frameworks like HuggingFace Understand the performance and efficiency advantages Positron claims over NVIDIA's offerings Explore how the team's deep industry experience from companies like Grok and F5 Networks gives them an edge Gain insights into Positron's innovative use of FPGAs for rapid iteration before moving to custom chips Hear about the company's funding journey and current Series A raise Uncover valuable lessons for founders on competing against industry giants Learn more about the startup Skyfire Website: https://www.positron.ai/  Follow Thomas Sohmers on Linkedin: https://www.linkedin.com/in/trsohmers/  The Pact Honour The Startup Podcast Pact! If you have listened to TSP and gotten value from it, please: Follow, rate, and review us in your listening app Subscribe to the TSP Mailing List at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thestartuppodcast.beehiiv.com/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Secure your official TSP merchandise at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://shop.tsp.show/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow us on YouTube at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@startup-podcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Give us a public shout-out on LinkedIn or anywhere you have a social media following. Key links The Startup Podcast is sponsored by Vanta. Vanta helps businesses get and stay compliant by automating up to 90% of the work for the most in demand compliance frameworks. With over 200 integrations, you can easily monitor and secure the tools your business relies on. For a limited-time offer of US$1,000 off, go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.vanta.com/tsp⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Get your question in for our next Q&A episode: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://forms.gle/NZzgNWVLiFmwvFA2A⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ The Startup Podcast website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://tsp.show⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Learn more about Chris and Yaniv Work 1:1 with Chris: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://chrissaad.com/advisory/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Chris on Linkedin: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/chrissaad/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Yaniv on Linkedin: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/ybernstein/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Credits Editor: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Justin McArthur⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Content Strategist: Carolina Franco https://www.linkedin.com/in/francocarolina/ Intro Voice: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Jeremiah Owyang⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Wes McKinney and I chat about Positron, Arrow, how he created Pandas and Arrow, and what makes him tick.

Prof. Mark Solms, a neuroscientist and psychoanalyst, discusses his groundbreaking work on consciousness, challenging conventional cortex-centric views and emphasizing the role of brainstem structures in generating consciousness and affect. MLST is sponsored by Brave: The Brave Search API covers over 20 billion webpages, built from scratch without Big Tech biases or the recent extortionate price hikes on search API access. Perfect for AI model training and retrieval augmentated generation. Try it now - get 2,000 free queries monthly at http://brave.com/api. Key points discussed: The limitations of vision-centric approaches to consciousness studies. Evidence from decorticated animals and hydranencephalic children supporting the brainstem's role in consciousness. The relationship between homeostasis, the free energy principle, and consciousness. Critiques of behaviorism and modern theories of consciousness. The importance of subjective experience in understanding brain function. The discussion also explored broader topics: The potential impact of affect-based theories on AI development. The role of the SEEKING system in exploration and learning. Connections between neuroscience, psychoanalysis, and philosophy of mind. Challenges in studying consciousness and the limitations of current theories. Mark Solms: https://neuroscience.uct.ac.za/contacts/mark-solms Show notes and transcript: https://www.dropbox.com/scl/fo/roipwmnlfmwk2e7kivzms/ACjZF-VIGC2-Suo30KcwVV0?rlkey=53y8v2cajfcgrf17p1h7v3suz&st=z8vu81hn&dl=0 TOC (*) are best bits 00:00:00 1. Intro: Challenging vision-centric approaches to consciousness * 00:02:20 2. Evidence from decorticated animals and hydranencephalic children * 00:07:40 3. Emotional responses in hydranencephalic children 00:10:40 4. Brainstem stimulation and affective states 00:15:00 5. Brainstem's role in generating affective consciousness * 00:21:50 6. Dual-aspect monism and the mind-brain relationship 00:29:37 7. Information, affect, and the hard problem of consciousness * 00:37:25 8. Wheeler's participatory universe and Chalmers' theories 00:48:51 9. Homeostasis, free energy principle, and consciousness * 00:59:25 10. Affect, voluntary behavior, and decision-making 01:05:45 11. Psychoactive substances, REM sleep, and consciousness research 01:12:14 12. Critiquing behaviorism and modern consciousness theories * 01:24:25 13. The SEEKING system and exploration in neuroscience Refs: 1. Mark Solms' book "The Hidden Spring" [00:20:34] (MUST READ!) https://amzn.to/3XyETb3 2. Karl Friston's free energy principle [00:03:50] https://www.nature.com/articles/nrn2787 3. Hydranencephaly condition [00:07:10] https://en.wikipedia.org/wiki/Hydranencephaly 4. Periaqueductal gray (PAG) [00:08:57] https://en.wikipedia.org/wiki/Periaqueductal_gray 5. Positron Emission Tomography (PET) [00:13:52] https://en.wikipedia.org/wiki/Positron_emission_tomography 6. Paul MacLean's triune brain theory [00:03:30] https://en.wikipedia.org/wiki/Triune_brain 7. Baruch Spinoza's philosophy of mind [00:23:48] https://plato.stanford.edu/entries/spinoza-epistemology-mind 8. Claude Shannon's "A Mathematical Theory of Communication" [00:32:15] https://people.math.harvard.edu/~ctm/home/text/others/shannon/entropy/entropy.pdf 9. Francis Crick's "The Astonishing Hypothesis" [00:39:57] https://en.wikipedia.org/wiki/The_Astonishing_Hypothesis 10. Frank Jackson's Knowledge Argument [00:40:54] https://plato.stanford.edu/entries/qualia-knowledge/ 11. Mesolimbic dopamine system [01:11:51] https://en.wikipedia.org/wiki/Mesolimbic_pathway 12. Jaak Panksepp's SEEKING system [01:25:23] https://en.wikipedia.org/wiki/Jaak_Panksepp#Affective_neuroscience

Positron Corporation (OTC: POSC), a leading molecular imaging medical device company offering Positron Emission Tomography/Computed Tomography (PET and PET-CT) imaging systems and clinical services, is pleased to announce its membership in the national alliance Cardiac PET Industry Coalition, an organization at the forefront of quality of patient care, advocacy and innovation to advance the field of cardiovascular PET imaging. Forbes has published 2024 Forbes The Global 2000 ranking. Ping An Insurance (Group) Company of China , Ltd. (HKEX: 2318 / 82318; SSE: 601318) ranked 29th among global enterprises. It is number 2 among global insurance companies, number 6 among Chinese companies and number 1 among China's insurance companies. For more information, please visit StockDayMedia.com

Could the universe be composed of a single electron? Neil deGrasse Tyson and co-hosts Chuck Nice and Gary O'Reilly answer grab-bag questions about the multidimensionality of time, quantum chromodynamics, gluons, tachyons, and more with astrophysicist Charles Liu. NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free.Thanks to our Patrons Jason Byttow, Keith Bale, Daniel Levin, Multimedia Kart, Renata, CESAR FRADIQUE, Ginger Towers, handzman, Lisa Kohler, and 21Pandas_ for supporting us this week.

What happens to quarks during spaghettification? Neil deGrasse Tyson and comedian Chuck Nice answer fan questions about positrons, how we got the speed of light, where the Big Bang took place, and more!NOTE: StarTalk+ Patrons can listen to this entire episode commercial-free here: https://startalkmedia.com/show/cosmic-queries-infinite-quarks/Thanks to our Patrons Eternal Sunshine, LLC, Arthur Brown, James Turner, Taygen Mercier, Bayley, Aaron, and Pete Sherburne for supporting us this week.